Hayton C - Search Results

1

Barriers to pulmonary rehabilitation: characteristics that predict patient attendance and adherence.

Hayton C, Clark A, Olive S, Browne P, Galey P, Knights E, Staunton L, Jones A, Coombes E, Wilson AM. Hayton C, et al. Respir Med. 2013 Mar;107(3):401-7. doi: 10.1016/j.rmed.2012.11.016. Epub 2012 Dec 19. Respir Med. 2013. PMID: 23261311 Free article.

2

Changes in lung epithelial cell volatile metabolite profile induced by pro-fibrotic stimulation with TGF-β1.

Hayton C, Ahmed W, Cunningham P, Piper-Hanley K, Pearmain L, Chaudhuri N, Leonard C, Blaikley JF, Fowler SJ. Hayton C, et al. J Breath Res. 2023 Sep 7;17(4). doi: 10.1088/1752-7163/acf391. J Breath Res. 2023. PMID: 37619557

3

Breath biomarkers in idiopathic pulmonary fibrosis: a systematic review.

Hayton C, Terrington D, Wilson AM, Chaudhuri N, Leonard C, Fowler SJ. Hayton C, et al. Respir Res. 2019 Jan 11;20(1):7. doi: 10.1186/s12931-019-0971-8. Respir Res. 2019. PMID: 30634961 Free PMC article.

4

The role of measuring exhaled breath biomarkers in sarcoidosis: a systematic review.

Terrington DL, Hayton C, Peel A, Fowler SJ, Fraser W, Wilson AM. Terrington DL, et al. Among authors: hayton c. J Breath Res. 2019 Jun 24;13(3):036015. doi: 10.1088/1752-7163/ab1284. J Breath Res. 2019. PMID: 30901768

5

Mycophenolate and azathioprine efficacy in interstitial lung disease: a systematic review and meta-analysis.

Lombardi F, Stewart I, Fabbri L, Adams W, Kawano-Dourado L, Ryerson CJ, Jenkins G; REMAP-ILD Consortium. Lombardi F, et al. BMJ Open Respir Res. 2024 Feb 27;11(1):e002163. doi: 10.1136/bmjresp-2023-002163. BMJ Open Respir Res. 2024. PMID: 38413120 Free PMC article.

6

Managing Idiopathic Pulmonary Fibrosis: Which Drug for Which Patient?

Hayton C, Chaudhuri N. Hayton C, et al. Drugs Aging. 2017 Sep;34(9):647-653. doi: 10.1007/s40266-017-0488-0. Drugs Aging. 2017. PMID: 28861727 Review.

7

Idiopathic pulmonary fibrosis: a holistic approach to disease management in the antifibrotic age.

Shaw J, Marshall T, Morris H, Hayton C, Chaudhuri N. Shaw J, et al. Among authors: hayton c. J Thorac Dis. 2017 Nov;9(11):4700-4707. doi: 10.21037/jtd.2017.10.111. J Thorac Dis. 2017. PMID: 29268540 Free PMC article. Review.

8

Idiopathic Pulmonary Fibrosis (IPF): An Overview.

Barratt SL, Creamer A, Hayton C, Chaudhuri N. Barratt SL, et al. Among authors: hayton c. J Clin Med. 2018 Aug 6;7(8):201. doi: 10.3390/jcm7080201. J Clin Med. 2018. PMID: 30082599 Free PMC article. Review.

9

Nintedanib in the management of idiopathic pulmonary fibrosis: clinical trial evidence and real-world experience.

Rivera-Ortega P, Hayton C, Blaikley J, Leonard C, Chaudhuri N. Rivera-Ortega P, et al. Among authors: hayton c. Ther Adv Respir Dis. 2018 Jan-Dec;12:1753466618800618. doi: 10.1177/1753466618800618. Ther Adv Respir Dis. 2018. PMID: 30249169 Free PMC article. Review.

10

Drug-Induced Interstitial Lung Disease: A Systematic Review.

Skeoch S, Weatherley N, Swift AJ, Oldroyd A, Johns C, Hayton C, Giollo A, Wild JM, Waterton JC, Buch M, Linton K, Bruce IN, Leonard C, Bianchi S, Chaudhuri N. Skeoch S, et al. Among authors: hayton c. J Clin Med. 2018 Oct 15;7(10):356. doi: 10.3390/jcm7100356. J Clin Med. 2018. PMID: 30326612 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

22 results

Search Page